Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

162,518 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibition of colon cancer metastasis by a 3'- end antisense urokinase receptor mRNA in a nude mouse model.
Wang Y, Liang X, Wu S, Murrell GA, Doe WF. Wang Y, et al. Int J Cancer. 2001 Apr 15;92(2):257-62. doi: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1178>3.0.co;2-6. Int J Cancer. 2001. PMID: 11291054
Docosahexaenoic Acid Modulates Invasion and Metastasis of Human Ovarian Cancer via Multiple Molecular Pathways.
Wang YC, Wu YN, Wang SL, Lin QH, He MF, Liu QL, Wang JH. Wang YC, et al. Among authors: wang sl, wang jh. Int J Gynecol Cancer. 2016 Jul;26(6):994-1003. doi: 10.1097/IGC.0000000000000746. Int J Gynecol Cancer. 2016. PMID: 27258728 Free PMC article.
Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.
Yang JL, Seetoo Dq, Wang Y, Ranson M, Berney CR, Ham JM, Russell PJ, Crowe PJ. Yang JL, et al. Among authors: wang y. Int J Cancer. 2000 Sep 20;89(5):431-9. doi: 10.1002/1097-0215(20000920)89:5<431::aid-ijc6>3.0.co;2-v. Int J Cancer. 2000. PMID: 11008205
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
Suzuki S, Hayashi Y, Wang Y, Nakamura T, Morita Y, Kawasaki K, Ohta K, Aoyama N, Kim SR, Itoh H, Kuroda Y, Doe WF. Suzuki S, et al. Among authors: wang y. Gut. 1998 Dec;43(6):798-805. doi: 10.1136/gut.43.6.798. Gut. 1998. PMID: 9824607 Free PMC article.
Expression of urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer.
Kawasaki K, Hayashi Y, Wang Y, Suzuki S, Morita Y, Nakamura T, Narita K, Doe W, Itoh H, Kuroda Y. Kawasaki K, et al. Among authors: wang y. J Gastroenterol Hepatol. 1998 Sep;13(9):936-44. doi: 10.1111/j.1440-1746.1998.tb00765.x. J Gastroenterol Hepatol. 1998. PMID: 9794194
Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
Ahmed N, Oliva K, Wang Y, Quinn M, Rice G. Ahmed N, et al. Among authors: wang y. Br J Cancer. 2003 Jul 21;89(2):374-84. doi: 10.1038/sj.bjc.6601098. Br J Cancer. 2003. PMID: 12865932 Free PMC article.
The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.
Wang Y. Wang Y. Med Res Rev. 2001 Mar;21(2):146-70. doi: 10.1002/1098-1128(200103)21:2<146::aid-med1004>3.0.co;2-b. Med Res Rev. 2001. PMID: 11223863 Review.
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
Xie C, Jiang XH, Zhang JT, Sun TT, Dong JD, Sanders AJ, Diao RY, Wang Y, Fok KL, Tsang LL, Yu MK, Zhang XH, Chung YW, Ye L, Zhao MY, Guo JH, Xiao ZJ, Lan HY, Ng CF, Lau KM, Cai ZM, Jiang WG, Chan HC. Xie C, et al. Among authors: wang y. Oncogene. 2013 May 2;32(18):2282-91, 2291.e1-7. doi: 10.1038/onc.2012.251. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797075
Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure.
Wang Y, Pratt JR, Hartley B, Evans B, Zhang L, Sacks SH. Wang Y, et al. Kidney Int. 1997 Aug;52(2):371-7. doi: 10.1038/ki.1997.343. Kidney Int. 1997. PMID: 9263992
High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer.
Lu J, Wang SL, Wang YC, Wu YN, Yu X, Zhao WZ, Wang JH. Lu J, et al. Among authors: wang sl, wang yc, wang jh. Oncotarget. 2017 Jun 20;8(25):41189-41201. doi: 10.18632/oncotarget.17141. Oncotarget. 2017. PMID: 28476025 Free PMC article.
162,518 results
Jump to page
Feedback